{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Intel, ConsenSys Health Advance Pandemic Research - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"rC75HIyOIR\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/\">Intel, ConsenSys Health Advance Pandemic Research<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/intel-consensys-health-advance-pandemic-research\/embed\/#?secret=rC75HIyOIR\" width=\"600\" height=\"338\" title=\"&#8220;Intel, ConsenSys Health Advance Pandemic Research&#8221; &#8212; Market Newsdesk\" data-secret=\"rC75HIyOIR\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Intel, ConsenSys Health Advance Pandemic Research ConsenSys Health applies privacy-preserving blockchain security, with support from Intel\u2019s Pandemic Response Technology Initiative, to help combat COVID-19. SANTA CLARA, Calif.&#8211;(BUSINESS WIRE)&#8211;What\u2019s New: Healthcare software solutions provider ConsenSys Health is using blockchain-based data security fueled by Intel technology to conduct research into making clinical trial recruitment more efficient and equitable. On the heels of the World Health Organization\u2019s (WHO) first global report on the use of artificial intelligence (AI) for healthcare and medicine, ConsenSys Health is seizing opportunities to apply innovative technology that helps protect patient privacy while increasing efficiency with the goal of combating the coronavirus. \u201cLong-standing industry challenges have only intensified throughout the COVID-19 pandemic. This is especially true for marginalized communities &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210810005175r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"}